Patents/Assignees

Arrowhead Pharmaceuticals, Inc.

29 patents in portfolio

US11920134utility2024
Compositions and Methods for Inhibiting Expression of RRM2 Genes
0 cites
US11912997utility2024
Rnai Agents for Inhibiting Expression of Superoxide Dismutase 1 (SOD1), Compositions Thereof, and Methods of Use
0 cites
US11884920utility2024
Alpha-1 Antitrypsin (AAT) Rnai Agents, Compositions Including AAT Rnai Agents, and Methods of Use
0 cites
US11845937utility2023
Rnai Agents for Inhibiting Expression of DUX4, Compositions Thereof, and Methods of Use
0 cites
US11840688utility2023
Compositions and Methods for Inhibiting Gene Expression of Hif2alpha
0 cites
US11629349utility2023
Rnai Agents for Inhibiting Expression of Xanthine Dehydrogenase (XDH), Pharmaceutical Compositions Thereof, and Methods of Use
0 cites
US11597701utility2023
Integrin Ligands and Uses Thereof
0 cites
US11590156utility2023
Rnai Agents for Hepatitis B Virus Infection
0 cites
US11549112utility2023
Rnai Agents for Inhibiting Expression of Xanthine Dehydrogenase (XDH), Pharmaceutical Compositions Thereof, and Methods of Use
0 cites

← PreviousPage 2 of 2